TriSalus Life Sciences, Inc. (TLSI) Financials

TLSI Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 62.4 million 55.9 million
March 31, 2026 71.0 million 58.2 million
Dec. 31, 2025 35.3 million 69.2 million
Sept. 30, 2025 36.5 million 63.2 million

TLSI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -16.8 million 5.1 million
March 31, 2026 -6.6 million 2.5 million
Dec. 31, 2025 -2.5 million 2.2 million
Sept. 30, 2025 -3.9 million 3.4 million

TLSI Net Income

No data available :(

TLSI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 46.3 million 33.1 million 1.4 million
March 31, 2026 56.6 million 34.3 million 218000
Dec. 31, 2025 20.4 million 34.3 million 167000
Sept. 30, 2025 22.7 million 34.0 million 129000

TLSI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 58.3 million
March 31, 2026 52.3 million
Dec. 31, 2025 46.8 million
Sept. 30, 2025 43.1 million

TLSI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 223000 3.1 million 16.6 million 11.4 million
March 31, 2026 141000 3.2 million 12.9 million 7.4 million
Dec. 31, 2025 41000 2.6 million 12.1 million 8.0 million
Sept. 30, 2025 216000 5.2 million 13.5 million 6.8 million

TLSI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 11.4 million 1.5 million
March 31, 2026 8.9 million 1.2 million
Dec. 31, 2025 13.2 million 1.8 million
Sept. 30, 2025 11.6 million 1.9 million

TLSI

Price: $5.24

52 week price:
2.20
7.95

Earnings Per Share: -1.32 USD

Exchange: NGM

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 351.6 million

Links: